To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A large national and international study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups. Published in Nature ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about understanding Gleason Score and prostate cancer risk. As part of its Speaking ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...

In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...

NHS England will collect patient information on 100 genes linked to an increased risk of cancer, in a bid to identify those ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...